ARCHIVES

In Brief: Recompetition Of Frederick Contract Flops, As Others Leave The Field To Litton-Bionetics

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

AACR Opposes Human Life Bill; ASCO Backs Cancer Act, Reimbursement

May 8, 1981

DCE Board Approves concept For New Studies On Black, White Differences In Cancer Rates

July 13, 1984

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

UT Health Science Center dedicates new Children’s Cancer Research Institute.

March 12, 2004

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011

Barret’s Less of a Risk Factor For Cancer of the Esophagus

June 24, 2011